The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification

被引：4

作者：

Nachtkamp, K. ^{[1
]}

Strupp, C. ^{[1
]}

Vukelja, M. ^{[1
]}

Kasprzak, A. ^{[1
]}

Haase, D. ^{[2
]}

Ganster, C. ^{[2
]}

Hildebrandt, B. ^{[3
]}

Betz, B. ^{[3
]}

Giagounidis, A. ^{[4
]}

Aul, C. ^{[5
]}

Blum, S. ^{[6
,7
]}

Hofmann, W. K. ^{[8
]}

Pfeilstoecker, M. ^{[9
,10
,11
]}

Valent, P. ^{[10
,11
,12
]}

Luebbert, M. ^{[13
]}

Seidl, M. ^{[14
]}

Rudelius, M. ^{[14
]}

Stauder, R. ^{[15
]}

Krieger, O. ^{[16
]}

Goetze, K. S. ^{[17
]}

Bobak, J. ^{[1
]}

Kuendgen, A. ^{[1
]}

Schulz, F. ^{[1
]}

Dietrich, S. ^{[1
]}

Kobbe, G. ^{[1
]}

Gattermann, N. ^{[1
]}

Germing, U. ^{[1
]}

机构：

[1] Heinrich Heine Univ, Dept Hematol Oncol & Clin Immunol, Dusseldorf, Germany

[2] Georg August Univ, Dept Hematol & Med Oncol, D-37099 Gottingen, Germany

[3] Heinrich Heine Univ, Inst Human Genet, Dusseldorf, Germany

[4] Marien Hosp, Dept Hematol Oncol & Palliat Care, Dusseldorf, Germany

[5] Johannes Hosp, Dept Hematol Oncol & Clin Immunol, Duisburg, Germany

[6] CHU Vaudois, Dept Oncol, Serv Hematol, Lausanne, Switzerland

[7] Lausanne Univ UNIL, Lausanne, Switzerland

[8] Univ Hosp, Dept Hematol & Oncol, Mannheim, Germany

[9] Hanusch Hosp, Med Dept Hematol & Oncol 3, Vienna, Austria

[10] Hanusch Hosp, Ludwig Boltzmann Inst Hematol & Oncol, Vienna, Austria

[11] Med Univ Vienna, Vienna, Austria

[12] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria

[13] Univ Freiburg, Dept Hematol & Oncol, Med Ctr, Freiburg, Germany

[14] Heinrich Heine Univ, Inst Pathol, Dusseldorf, Germany

[15] Med Univ, Dept Internal Med, Innsbruck, Austria

[16] Elisabethinen Hosp, Linz, Austria

[17] Tech Univ Munich TUM, Dept Med 3, Klinikum Rechts Isar, Munich, Germany

来源：

LEUKEMIA | 2024年 / 38卷 / 02期

关键词：

IMPACT;

D O I：

10.1038/s41375-024-02157-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：386 / 388

页数：3

共 14 条

[1] The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification
K. Nachtkamp
C. Strupp
M. Vukelja
A. Kasprzak
D. Haase
C. Ganster
B. Hildebrandt
B. Betz
A. Giagounidis
C. Aul
S. Blum
W. K. Hofmann
M. Pfeilstöcker
P. Valent
M. Lübbert
M. Seidl
M. Rudelius
R. Stauder
O. Krieger
K. S. Götze
J. Bobak
A. Kündgen
F. Schulz
S. Dietrich
G. Kobbe
N. Gattermann
U. Germing
Leukemia, 2024, 38 : 442 - 445
[2] Validation of the WHO proposals for the classification of unclassifiable myelodysplastic syndromes
Germing, U.
Nachtkamp, K.
Strupp, C.
Hildebrandt, B.
Haas, R.
Giagounidis, A.
Kuendgen, A.
Gattermann, N.
LEUKEMIA RESEARCH, 2009, 33 : S35 - S35
[3] Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes
Germing, Ulrich
Strupp, Corinna
Kuendgen, Andrea
Isa, Shadi
Knipp, Sabine
Hildebrandt, Barbara
Giagounidis, Aristoteles
Aul, Carlo
Gattermann, Norbert
Haas, Rainer
HAEMATOLOGICA, 2006, 91 (12) : 1596 - 1604
[4] Comparison of the 2022 ICC and Who Classification Systems of Myelodysplastic Neoplasms
Wu, Junying
Zhang, Yudi
Qin, Tiejun
Xu, Zefeng
Qu, Shiqiang
Pan, Li Juan
Gale, Robert Peter
Li, Bing
Xiao, Zhijian
BLOOD, 2023, 142
[5] Validation of and proposals for refinements of the WHO 2016 classification for myelodysplastic syndromes
van Spronsen, Margot F.
Westers, Theresia M.
Rozema, Hanne
Ossenkoppele, Gert J.
Kibbelaar, Robby E.
Hoogendoorn, Mels
van de Loosdrecht, Arjan A.
AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (11) : E631 - E634
[6] Validation of the WHO proposals for a new classification of myelodysplastic syndromes: Analysis of 1640 patients.
Germing, U
Gattermann, N
Strupp, C
Aivado, M
Aul, C
BLOOD, 2000, 96 (11) : 547A - +
[7] Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients
Germing, U
Gattermann, N
Strupp, C
Aivado, M
Aul, C
LEUKEMIA RESEARCH, 2000, 24 (12) : 983 - 992
[8] The clinical, molecular, and prognostic features of the 2022 WHO and ICC classification systems for myelodysplastic neoplasms
Khanna, Vishesh
Lu, Rong
Kumar, Jyoti
Molina, Alfonso
Stehr, Henning
Spiteri, Elizabeth
Spinner, Michael
Silva, Oscar
Fernandez-Pol, Sebastian
Tan, Brent
Greenberg, Peter L.
LEUKEMIA RESEARCH, 2024, 136
[9] Validation and proposals for a refinement of the WHO 2008 classification of myelodysplastic syndromes without excess of blasts
Maassen, Anna
Strupp, Corinna
Giagounidis, Aristoteles
Kuendgen, Andrea
Nachtkamp, Kathrin
Hildebrandt, Barbara
Gattermann, Norbert
Aul, Carlo
Haas, Rainer
Germing, Ulrich
LEUKEMIA RESEARCH, 2013, 37 (01) : 64 - 70
[10] Characterization of Clinical, Molecular, and Prognostic Features of the WHO 2022 Classification System for Myelodysplastic Neoplasms (MDS)
Khanna, Vishesh
Lu, Rong
Kumar, Jyoti
Stehr, Henning
Spinner, Michael A.
Silva, Oscar
Fernandez-Pol, Sebastian
Oak, Jean S.
Tan, Brent
Greenberg, Peter L.
BLOOD, 2022, 140 : 6955 - 6957

← 1 2 →